Pegylated (40 KDA) interferon alfa-2a (PEGASYS®) in new combination therapies: a report of a randomized, multicenter efficacy and safety study
Year: 2001
Type: article
Source: Journal of Hepatology
Authors: A.M. Di Bisceglie, D.E. Bernstein, V.R. Rustgi, N. Gitlin, L.J. Jeffers, D. Simon, J. Campagna, S.C. Pappas
Language: English
Topic: Hepatitis C virus research
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2134578704